AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
AntiCan↑, ROS↑, mtDam↑, tumCV↓, selectivity↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
AntiCan↑, tumCV↓, Bcl-2↓, PI3K↓, mTOR↓, NF-kB↓, BAX↑, *AntiDiabetic↑, *AntiCan↑, *Inflam↓, *antiOx↑, *neuroP↑,
| - |
in-vitro, |
Colon, |
HCT116 |
|
|
|
- |
Review, |
IBD, |
RAW264.7 |
|
|
|
*Inflam↓, AntiCan↑, *NF-kB↓, *MAPK↓, *colonLen↑, TumCG↓, Apoptosis↑, LC3II↑, Beclin-1↑, cl‑Casp3↑, BAX↑, Bcl-2↓, IGF-1↓, ACLY↓, Acetyl-CoA↓, Fas↓, HSL/LIPE↓, ATGL/PNPLA2↓, FFA↓, GSK‐3β↑, p‑mTOR↓, Rictor↓, p‑Akt↓, PDE3B↓, p‑PKA↓, p‑HSL/LIPE↑, TumAuto↑,
Apoptosis↑, *Inflam↓, AntiCan↑, lipid-P↑, COX2↝, MKP1↝,
| - |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP/DDIT3↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
| - |
in-vivo, |
Colon, |
CT26 |
|
|
|
- |
in-vitro, |
NA, |
MCF7 |
|
|
|
- |
in-vitro, |
NA, |
SkBr3 |
|
|
|
AntiCan↑, SVCT-2↝, TumCD↑, ROS↑, P21↑, proCasp3↑, TumVol↓, DNAdam↑, NAD↓,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
ATGL/PNPLA2↓, 1, FFA↓, 1, HSL/LIPE↓, 1, p‑HSL/LIPE↑, 1, PDE3B↓, 1, Rictor↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
lipid-P↑, 1, ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mtDam↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Acetyl-CoA↓, 1, ACLY↓, 1, NAD↓, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↑, 3, BAX↑, 2, Bcl-2↓, 2, BIM↑, 1, cl‑Casp3↑, 1, proCasp3↑, 1, Fas↓, 1, GADD34↑, 1, MKP1↝, 1, PUMA↑, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1↑, 1, LC3II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
GSK‐3β↑, 1, IGF-1↓, 1, mTOR↓, 1, p‑mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↝, 1, p‑PKA↓, 1,
Barriers & Transport(tgid=15) ⓘ
SVCT-2↝, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↝, 1, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
selectivity↑, 2,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 6, TumVol↓, 1,
Total Targets: 45
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
colonLen↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Cell Death(tgid=5) ⓘ
MAPK↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 3, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1, neuroP↑, 1,
Total Targets: 9
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page